Discover the detailed record of transactions filed by Campbell Bradley L, 首席运营官. Insider active across 2 companies, notably Amicus Therapeutics, INC.. In total, 76 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €944k. Activity tracked since 3 May 2021. The latest transaction was filed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Campbell Bradley L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Campbell Bradley L is Directeur des Opérations and has reported 76 filings in total. Across the 76 sampled recent filings, all relate to Amicus Therapeutics, INC., with EUR 0 of buys and EUR 13419788 of sells, mainly over the period from 2016-01-06 to 2026-04-27. The most frequent transaction nature is Levée d'options.